10:01 AM EDT, 05/15/2025 (MT Newswires) -- Curaleaf Holdings ( CURLF ) on Thursday said its Curaleaf International launched a range of medical cannabis products in Australia.

The company said that the initial product offering, consisting of four cannabis flower strains, will be distributed through Canngea, a licensed Australian manufacturer and wholesaler with experience in medical cannabis.

"Australia is an exciting and rapidly evolving market, expected to surpass $1 billion in annual sales next year, and this launch is a positive step forward in our strategy to extend our position as the global leader in cannabis," said Curaleaf's ( CURLF ) Chairman and Chief Executive Officer Boris Jordan. "We're bringing a proven portfolio and a strong track record of innovation, with more to come."

"Entering the Australian market is a significant milestone in our global strategy to expand access to high-quality, evidence-backed cannabis medicines," said Juan Martinez, Head of Curaleaf International. "We're committed to supporting Australian patients and healthcare professionals with reliable, consistent products and the backing of one of the industry's most advanced supply chains."

Price: 1.21, Change: -0.02, Percent Change: -1.63